Note: Ingredients listed on restricted chemical lists
EC/CAS
247-852-1/26628-22-8
Name of the chemical
Sodium Azide
Concentration
=0,1-<0,25
EC/CAS
55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
>=0,0015-< >=0,6% 0,06-<0,6% 0,06-<0,6% >=0,0015% >=0,6%
General Information
Revision date
2021-12-22
Product name
SARS-CoV-2 & FluA/B Rapid Antigen Test
Emergency telephone
+44 1444 256500, +44 1444 256561, +44 844 892 0111, +44 845 4647, +44 8454 242424, +44 7710 - 391653
Icons in SDS
Company Information
company name
Roche Diagnostics Limited
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H412
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
The product is a kit consisting of individual ingredients. The classification of the ingredients can be obtained from section 3. Section Label elements contains the resulting labelling for the kit.
Signal word
Warning
Hazard statements
H317 May cause an allergic skin reaction. H412 Harmful to aquatic life with long lasting effects.
Prevention
P261 Avoid breathing mist or vapours. P273 Avoid release to the environment. P280 Wear protective gloves.
Response
P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P362 + P364 Take off contaminated clothing and wash it before reuse.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regu- lation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
